Marksans Pharma (MARKSANS) — Board Meeting

📢 Key Event
Board approved Q1 June 2026 financial results and strategic acquisitions.

💡 Investor Takeaway
The company delivered stronger quarterly profits and expanded its global footprint through recent acquisitions, signaling growth momentum for shareholders.

The Board approved unaudited standalone and consolidated financial results for Q1 June 2026, showing revenue of ₹3,386.57 crores and ₹8,662.00 crores respectively, with profit after tax of ₹690.37 crores and ₹1,594.07 crores. The standalone EPS was [amount context mismatch] and consolidated EPS [amount not verified]. The meeting also approved the acquisition of QliniQ B.V. for EUR 7.50 million and a subsequent purchase of ABCnow GmbH for EUR 1.10 million.

📄 View Original Announcement (PDF)

📊 Stock Analysis — MARKSANS ✨ Ask AI About This

About Marksans Pharma Limited (MARKSANS)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹14,634.92 Cr P/E: 28.3 ROE: 17.2% ROCE: 23.4% Div Yield: 0.28%

View full MARKSANS stock details →

📡 Get AI alerts when MARKSANS files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track MARKSANS — Free

💡 Ask AI about this filing

"How will the QliniQ acquisition impact profitability?" "What is the expected revenue contribution from ABCnow?" "When will full financials for the new subsidiaries be available?"

Ask AI Free →

📊 More MARKSANS filings

See all MARKSANS filings →

🔥 Also filed on 12 August 2026

DBL Dilip Buildcon Limited Corporate Action NITCO Nitco Limited Financial Results KPIGREEN KPI Green Energy Limited Financial Results SDBL Som Distilleries & Breweries Limited Financial Results CONSOFINVT Consolidated Finvest & Holdings Limited Corporate Action TOUCHWOOD Touchwood Entertainment Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when MARKSANS files new disclosures

Track MARKSANS filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track MARKSANS — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd